RT Journal Article
SR Electronic
T1 National Changes in Diabetes Care Practices during the COVID-19 Pandemic: Prospective Study of US Adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.06.23293722
DO 10.1101/2023.08.06.23293722
A1 Vashist, Kushagra
A1 Hassan, Saria
A1 Weber, Mary Beth
A1 Quarells, Rakale C.
A1 Patel, Shivani A.
YR 2023
UL http://medrxiv.org/content/early/2023/08/09/2023.08.06.23293722.abstract
AB Background There is a lack of nationally representative prospective data on the impact of the COVID-19 pandemic on diabetes care and management in adults with type 2 diabetes. We examined changes in diabetes care and management practices before and after the onset of the COVID-19 pandemic.Methods Using the National Health Interview Survey, we analyzed data from 870 adults living with type 2 diabetes who were interviewed in 2019 and re-interviewed between August and December 2020. Exposure to the COVID-19 pandemic was defined by year of survey (2019, pre-pandemic; 2020, pandemic). We estimated percent change in past year blood sugar check by a health professional and current use of blood sugar lowering medication overall and by sociodemographic subgroups.Results Receiving an annual blood sugar test fell by -3.3 percentage points (pp) (95% CI -5.7, -1.0), from 98.3% in 2019 to 95.0% in late 2020. The reduction in annual blood glucose testing was largely consistent across socio-demographic groups and was particularly pronounced among adults not working and adults aged 65 years and older. In the same time period, current use of diabetes medications increased by +3.8 pp (0.7, 6.9), from 85.9% to 89.7%. The increase in medication use was most pronounced among individuals aged 40-64-year old, employed, and those living in large central metropolitan areas.Conclusions Nationally, adults with Type 2 diabetes reported a reduction in annual blood glucose testing by a health professional and an increase in diabetes medication usage during the COVID-19 pandemic. If sustained after the end of the COVID-19 public health emergency, these changes have implications for national diabetes management and care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKV, MBW, RCQ, and SAP were supported by grant number P30DK111024-05S2 from the National Institute of Health under the RADx® Underserved Populations (RADx-UP) Initiative (https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs), and MBW is supported by P30DK111024. SH is supported by a grant from the National Institute of Health/National Heart Lung and Blood Institute (K23HL152368) https://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used publicly available data containing no personal identifying information and is therefore deemed not human subjects research by the Emory IRB.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are held in public repository at CDC's website on NHIS data. https://www.cdc.gov/nchs/nhis/2020nhis.htm https://www.cdc.gov/nchs/nhis/2019nhis.htm https://www.cdc.gov/nchs/nhis/2020nhis.htm https://www.cdc.gov/nchs/nhis/2019nhis.htm